Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea

Company announces strategic relationship with ZOLL Medical MINNETONKA, Minn., Dec. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Respicardia, Inc., a private medical technology company, announced today that the company has closed a $58.5 millio... Devices, Venture Capital Respicardia, remedē System, ZOLL Medical, sleep apnea, neurostimulation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news